SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
Yesterday 7:37 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | Yesterday | Purchase | 505,954 | $9.79 | $4,953,290.00 | 5% 10.36M to 10.86M | |
Yesterday 7:37 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 26-Mar-24 | Purchase | 457,745 | $9.55 | $4,371,460.00 | 5% 9.9M to 10.36M | |
Yesterday 7:37 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 25-Mar-24 | Purchase | 437,600 | $9.06 | $3,964,660.00 | 5% 9.46M to 9.9M | |
25-Mar-24 8:48 PM View: | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Grant | 3,245,780 | -- | -- | 515% 629.79K to 3.88M | |
25-Mar-24 8:48 PM View: | Lenz Therapeutics, Inc. (LENZ) | 21-Mar-24 | Purchase | 998,009 | $15.03 | $15,000,100.00 | 26% 3.88M to 4.87M | |
06-Mar-24 10:00 PM View: | 89bio, Inc. (ETNB) | 04-Mar-24 | Purchase | 1,350,000 | $15.35 | $20,722,500.00 | 12% 11.42M to 12.77M | |
20-Feb-24 8:07 PM View: | Icosavax, Inc. (ICVX) | 19-Feb-24 | Disposition (change in control) | 5,969,110 | -- | -- | (100%) 5.97M to 0 | |
14-Feb-24 7:49 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 12-Feb-24 | Grant | 1,672,510 | $13.50 | $22,578,900.00 | 53% 3.18M to 4.85M | 5% |
13-Feb-24 4:33 PM View: | Pepgen Inc. (PEPG) | 09-Feb-24 | Purchase | 2,557,590 | $10.64 | $27,212,800.00 | 31% 8.13M to 10.69M | |
08-Feb-24 5:16 PM View: | Tyra Biosciences, Inc. (TYRA) | 06-Feb-24 | Grant | 3,180,160 | $13.01 | $41,373,800.00 | 44% 7.24M to 10.42M | (6%) |
12-Jan-24 5:01 PM View: | Solid Biosciences Inc. (SLDB) | 11-Jan-24 | Purchase | 904,160 | $5.53 | $5,000,000.00 | 27% 3.4M to 4.3M | |
13-Dec-23 4:33 PM View: | Wave Life Sciences Ltd. (WVE) | 11-Dec-23 | Purchase | 1,000,000 | $5.00 | $5,000,000.00 | 5% 18.2M to 19.2M | |
25-Sep-23 4:30 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 21-Sep-23 | Private Purchase | 2,700,000 | $3.03 | $8,183,530.00 | 18% 15.13M to 17.83M | |
31-Aug-23 5:26 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 29-Aug-23 | Purchase | 3,750,000 | $6.20 | $23,250,000.00 | 125% 3.01M to 6.76M | |
22-Aug-23 5:01 PM View: | An2 Therapeutics, Inc. (ANTX) | 18-Aug-23 | Private Purchase | 1,777,780 | $9.00 | $16,000,000.00 | 47% 3.77M to 5.55M | |
09-Aug-23 5:00 PM View: | Dice Therapeutics, Inc. (DICE) | 09-Aug-23 | Disposition (change in control) | 7,856,610 | -- | -- | (100%) 7.86M to 0 | |
25-Jul-23 4:30 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 21-Jul-23 | Purchase | 5,161,290 | $7.75 | $40,000,000.00 | 53% 9.77M to 14.93M | |
21-Jul-23 4:31 PM View: | Janux Therapeutics, Inc. (JANX) | 19-Jul-23 | Private Purchase | 495,008 | $12.46 | $6,167,800.00 | 6% 8.67M to 9.17M | |
07-Jul-23 4:30 PM View: | Black Diamond Therapeutics,... (BDTX) | 05-Jul-23 | Market Purchase | 935,850 | $5.00 | $4,679,250.00 | 36% 2.59M to 3.53M | (10%) |
12-Jun-23 8:23 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 08-Jun-23 | Disposition (change in control) | 5,914,250 | -- | -- | (100%) 5.91M to 0 | |
30-Mar-23 5:03 PM View: | Dice Therapeutics, Inc. (DICE) | 30-Mar-23 | Purchase | 195,997 | $28.74 | $5,632,950.00 | < 1% 21.34M to 21.54M | |
30-Mar-23 5:03 PM View: | Dice Therapeutics, Inc. (DICE) | 29-Mar-23 | Purchase | 66,369 | $29.38 | $1,949,920.00 | < 1% 21.28M to 21.34M | |
30-Mar-23 5:03 PM View: | Dice Therapeutics, Inc. (DICE) | 28-Mar-23 | Purchase | 246,779 | $29.24 | $7,215,820.00 | 1% 21.03M to 21.28M | |
27-Mar-23 5:01 PM View: | Dice Therapeutics, Inc. (DICE) | 27-Mar-23 | Purchase | 151,132 | $27.48 | $4,153,110.00 | < 1% 19.82M to 19.98M | |
27-Mar-23 5:01 PM View: | Dice Therapeutics, Inc. (DICE) | 24-Mar-23 | Purchase | 192,335 | $26.87 | $5,168,040.00 | < 1% 19.63M to 19.82M | |
30-Mar-23 5:00 PM View: | 89bio, Inc. (ETNB) | 24-Mar-23 | Purchase | 2,461,540 | $16.25 | $40,000,000.00 | 27% 8.96M to 11.42M | |
27-Mar-23 5:01 PM View: | Dice Therapeutics, Inc. (DICE) | 23-Mar-23 | Purchase | 155,089 | $26.67 | $4,136,220.00 | < 1% 19.48M to 19.63M | |
27-Feb-23 4:31 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Grant | 1,152,460 | -- | -- | 119% 970.0K to 2.12M | |
16-Feb-23 5:04 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 14-Feb-23 | Conversion | 1,928,480 | -- | -- | 100% 0 to 1.93M | |
16-Feb-23 5:04 PM View: | Mineralys Therapeutics, Inc. (MLYS) | 14-Feb-23 | Private Purchase | 1,250,000 | $16.00 | $20,000,000.00 | 65% 1.93M to 3.18M | |
24-Jan-23 4:30 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 20-Jan-23 | Private Purchase | 1,923,080 | $13.00 | $25,000,000.00 | 20% 9.69M to 11.61M | |
10-Jan-23 5:14 PM View: | Werewolf Therapeutics, Inc. (HOWL) | 06-Jan-23 | Private Purchase | 1,853,000 | $2.21 | $4,095,130.00 | 43% 4.29M to 6.14M | |
06-Jan-23 4:39 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 04-Jan-23 | Private Purchase | 180,703 | $7.28 | $1,314,810.00 | < 1% 19.13M to 19.31M | |
05-Jan-23 4:43 PM View: | Enliven Therapeutics, Inc. (ELVN) | 03-Jan-23 | Purchase | 629,297 | $4.00 | $2,516,060.00 | 19% 3.25M to 3.88M | |
29-Dec-22 5:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 27-Dec-22 | Private Purchase | 4,089 | $5.99 | $24,509.90 | < 1% 9.5M to 9.51M | |
21-Dec-22 4:30 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 19-Dec-22 | Private Purchase | 98,787 | $5.90 | $582,814.00 | 1% 9.4M to 9.5M | |
16-Dec-22 4:41 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 16-Dec-22 | Purchase | 1,341,420 | $5.42 | $7,269,830.00 | 6% 23.95M to 25.29M | |
16-Dec-22 4:41 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 15-Dec-22 | Purchase | 237,029 | $5.49 | $1,302,470.00 | < 1% 23.71M to 23.95M | |
16-Dec-22 4:41 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 14-Dec-22 | Private Purchase | 824,600 | $5.46 | $4,501,570.00 | 4% 22.89M to 23.71M | |
12-Dec-22 4:30 PM View: | Enliven Therapeutics, Inc. (ELVN) | 09-Dec-22 | Purchase | 19,299 | $3.93 | $75,845.10 | < 1% 6.46M to 6.48M | |
09-Dec-22 4:32 PM View: | Vor Biopharma Inc. (VOR) | 09-Dec-22 | Grant | 11,627,900 | $4.30 | $50,000,000.00 | 105% 11.12M to 22.75M | |
12-Dec-22 4:30 PM View: | Enliven Therapeutics, Inc. (ELVN) | 08-Dec-22 | Purchase | 10,600 | $3.75 | $39,750.00 | < 1% 6.45M to 6.46M | |
05-Dec-22 5:02 PM View: | Solid Biosciences Inc. (SLDB) | 02-Dec-22 | Grant | 2,573,190 | $5.93 | $15,250,000.00 | 312% 824.53K to 3.4M | |
21-Nov-22 4:31 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 17-Nov-22 | Conversion | 1,421,010 | -- | -- | 100% 0 to 1.42M | |
21-Nov-22 4:31 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 17-Nov-22 | Private Purchase | 3,389,500 | $12.50 | $42,368,800.00 | 239% 1.42M to 4.81M | |
10-Nov-22 6:00 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-Nov-22 | Grant | 3,009,680 | -- | -- | 100% 0 to 3.01M | |
24-Oct-22 4:41 PM View: | Enliven Therapeutics, Inc. (ELVN) | 24-Oct-22 | Purchase | 26,460 | $3.91 | $103,459.00 | < 1% 9.54M to 9.56M | |
24-Oct-22 4:41 PM View: | Enliven Therapeutics, Inc. (ELVN) | 21-Oct-22 | Purchase | 48,100 | $3.92 | $188,552.00 | < 1% 9.49M to 9.54M | |
24-Oct-22 4:41 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Oct-22 | Purchase | 11,342 | $3.95 | $44,800.90 | < 1% 9.48M to 9.49M | |
19-Oct-22 4:40 PM View: | Enliven Therapeutics, Inc. (ELVN) | 19-Oct-22 | Purchase | 125,726 | $3.89 | $488,659.00 | 1% 8.79M to 8.92M |